Lead sponsor
National University of Singapore
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
570
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2/3
1
Not applicable
1
Trials by status
Not yet recruiting
1
Recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical ClockBMI ≥27.5not applicableNot yet recruiting440